Interictal oscillations and focal epileptic disorders
Maxime Lévesque1, Pariya Salami1, Zahra Shiri1
1Department of Neurology & Neurosurgery, Montreal Neurological Institute, McGill University, 3801 University Street, Montréal, QC, Canada, H3A 2B4.
The European Journal of Neuroscience
|June 24, 2017
Summary
Interictal spikes and high-frequency oscillations (HFOs) are key EEG markers in epilepsy. Understanding their cellular generation mechanisms is crucial for localizing seizure onset and developing new epilepsy treatments.
Area of Science:
- Neuroscience
- Epileptology
- Computational Neuroscience
Background:
- Neuronal network oscillations are fundamental to brain activity, observable in EEG signals during both healthy and pathological states like epilepsy.
- Interictal oscillations, occurring between seizures, are classified as interictal spikes and high-frequency oscillations (HFOs) based on their frequency and waveform.
Purpose of the Study:
- To review the cellular mechanisms generating interictal spikes and HFOs in animal models of epilepsy.
- To explore the role of these oscillations in ictogenesis (seizure generation) and epileptogenesis (chronic epilepsy development).
Main Methods:
- Analysis of existing literature on interictal spikes and HFOs in animal models of focal epilepsy.
- Review of in vitro and in vivo studies investigating neuronal network excitability changes associated with these oscillations.
Main Results:
- Interictal spikes are large-amplitude, short-duration events in wideband EEG.
- HFOs, including ripples (80-200 Hz) and fast ripples (250-500 Hz), are detected in filtered EEG signals.
- These oscillations reflect dynamic alterations in neuronal network excitability.
Conclusions:
- Interictal spikes and HFOs are critical biomarkers for localizing the seizure onset zone in focal epilepsy.
- Understanding the cellular basis of these oscillations provides insights into the mechanisms driving seizure generation and epilepsy progression.
- This knowledge is vital for developing targeted surgical and therapeutic interventions for drug-resistant epilepsy.
Related Concept Videos
Epilepsy and Seizures: Overview
1.5K
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.5K
Seizures: Classification
1.9K
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
1.9K
Brain Waves
4.4K
Brain waves are electrical signals generated by the neurons in the brain, which are regularly monitored to measure mental activities. Brain waves and their frequency ranges can be measured using an electroencephalogram or EEG. There are four main types of brain waves, each with distinct characteristics:
4.4K
Antiepileptic Drugs: Potassium Channel Activators
864
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
864


